In comparison, NGS with gene panels comprising more than 300 cancer-associated genes in a study cohort encompassing 1324 patients with mBC identified alterations in TP53 in 41.5%, PIK3CA mutations in 35.4%, and FGFR1 alterations in 13.2% [26]. The gene discussed is TP53; the disease is cancer.